All novo nordisk ozempic Articles

Ozempic drugmaker selects BE&K for US factory expansion
Premium Content
Ozempic maker has selected a US-based firm for its new factory
Drug-maker Novo Nordisk to spend $4.1bn on construction of US Wegovy facility
Premium Content
Danish drug-maker Novo Nordisk is to spend $4.1 billion to build a new US facility to fill injection pens for its popular weight-loss treatment Wegovy
Demand for weight-loss drugs spurs Novo Nordisk to invest €2.1bn in French production site
Premium Content
Danish drug company Novo Nordisk is to invest 16 billion Danish kroner (€2.1 billion) to expand its production facilities in Chartres, France amid high demand for its weight-loss drugs Ozempic and Wegovy.